Wegovy vs. Zepbound
The Battle of the Weight Loss Approved Shots
Both are FDA-approved specifically for weight management, but they work differently. We compare Wegovy (Semaglutide) and the newer Zepbound (Tirzepatide) to help you decide.
🥊 Heavyweight Matchup📊 Weight Loss Data✅ FDA Approved
| Feature | Wegovy | Zepbound |
|---|---|---|
| Active Ingredient | Semaglutide | Tirzepatide |
| Max Dose | 2.4 mg | 15 mg |
| Efficacy (Trial) | 14.9% Weight Loss | 20.9% Weight Loss |
| FDA Indication | Obesity & Heart Health | Obesity Management |
The Case for Wegovy
Wegovy has a longer history of FDA approval for weight loss. Crucially, it recently gained a new FDA indication for reducing cardiovascular risk (heart attack/stroke) in overweight adults with cardiovascular disease.
The Case for Zepbound
Zepbound is the newer powerhouse. By adhering to both GLP-1 and GIP receptors, it tends to be more effective for pure weight loss in direct statistical comparisons. It's often the choice when maximum weight reduction is the priority.
Compare & Track Your Results
Monitor your weekly injections, side effects, and weight loss progress with Shotlee's free tracker.
🚀 Download Shotlee Free